Angiogenic response induced by acellular femoral matrix in vivo

J Anat. 2005 Jul;207(1):79-83. doi: 10.1111/j.1469-7580.2005.00427.x.

Abstract

We investigated the angiogenic response induced by acellular femoral matrices implanted in vivo on to the chick embryo chorioallantoic membrane (CAM), a useful model for such investigation. The results showed that acellular matrices were able to induce a strong angiogenic response, comparable with that of fibroblast growth factor-2 (FGF-2), a well-known angiogenic cytokine. The angiogenic response was further increased when exogenous FGF-2 or transforming growth factor beta-1 (TGF-beta1) was added to the matrices and inhibited by the addition of anti-FGF-2 or anti-TGF-beta1 antibodies. The response may be considered to be dependent on a direct angiogenic effect exerted by the matrices, and also in part by the presence of FGF-2 and TGF-beta1 in the acellular matrices.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents / immunology
  • Angiogenesis Inducing Agents / pharmacology
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Chick Embryo
  • Chorioallantoic Membrane / blood supply*
  • Extracellular Matrix / physiology
  • Extracellular Matrix / transplantation*
  • Femur*
  • Fibroblast Growth Factor 2 / pharmacology
  • Immunohistochemistry / methods
  • Neovascularization, Physiologic*
  • Rats
  • Tissue Culture Techniques
  • Transforming Growth Factor beta / immunology
  • Transforming Growth Factor beta / pharmacology
  • Transforming Growth Factor beta1

Substances

  • Angiogenesis Inducing Agents
  • Antibodies, Monoclonal
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta
  • Transforming Growth Factor beta1
  • Fibroblast Growth Factor 2